Yale School of Medicine


 

ACC 21 Highlights: Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction. Results of the LIFE Trial

243 views
June 14, 2021
Comments 0
Login to view comments. Click here to Login